The podcast explores the potential benefits and risks of various drugs, particularly psychedelics, on longevity and health. It distinguishes between drugs like cocaine, which significantly reduce lifespan due to cardiovascular risks, and psychedelics like ketamine, which show promise in treating PTSD and depression. A study involving ketamine infusions demonstrated a reduction in biological age among participants, though the effect may be secondary to improved mental health. Bryan Johnson shares his experience of ketamine's impact on brain activity using Kernel Flow, illustrating how it temporarily scrambles brain patterns, opening a therapeutic window for new ideas and behaviors. The discussion emphasizes the importance of fentanyl test strips and naloxone due to the prevalence of fentanyl-related deaths, especially among young adults.
Sign in to continue reading, translating and more.
Continue
